Significant increase in anxiety during aging in mGlu5 receptor knockout mice

Behavioural Brain Research

Volumn 241, Issue 1, 2013, Pages 27-31

  Inta, D ^a   Vogt, M A ^a   Luoni, A ^b   Filipovic D ^a,c   Lima Ojeda, J M ^a   Pfeiffer, N ^a   Gasparini, F ^d   Riva, M A ^b   Gass, P ^a  

^a MEDICAL FACULTY MANNHEIM HEIDELBERG UNIVERSITY   (Germany)

^b UNIVERSITY OF MILAN   (Italy)

^c UNIVERSITY OF BELGRADE   (Serbia)

^d NOVARTIS PHARMA AG   (Switzerland)

Author keywords

Aging; Anxiety; Deletion; Depression; Genetic; MGlu5

Indexed keywords

METABOTROPIC RECEPTOR 5;

AGING; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANXIETY; ARTICLE; CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; FORCED SWIMMING TEST; GENE DELETION; GENETIC ASSOCIATION; KNOCKOUT MOUSE; LOCOMOTION; MALE; MAZE TEST; MOUSE; NONHUMAN; OPEN FIELD TEST; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN FUNCTION;

AGE FACTORS; AGING; ANIMALS; ANXIETY; BEHAVIOR, ANIMAL; MICE; MICE, KNOCKOUT; MOTOR ACTIVITY; RECEPTORS, METABOTROPIC GLUTAMATE;

EID: 84871833960     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2012.11.042     Document Type: Article

References (24)

1. Niswender C.M., Conn P.J. Metabotropic glutamate receptors: physiology, pharmacology, and disease. Annual Review of Pharmacology and Toxicology 2010, 50:295-322.
2. Perroy J., Raynaud F., Homburger V., Rousset M.C., Telley L., Bockaert J., et al. Direct interaction enables cross-talk between ionotropic and group I metabotropic glutamate receptors. Journal of Biological Chemistry 2008, 283:6799-6805.
3. Gasparini F., Lingenhohl K., Stoehr N., Flor P.J., Heinrich M., Vranesic I., et al. 2-Methyl-6-(phenylethynyl)-pyridine (MPEP), a potent, selective and systemically active mGlu5 receptor antagonist. Neuropharmacology 1999, 38:1493-1503.
4. Tatarczynska E., Klodzinska A., Chojnacka-Wojcik E., Palucha A., Gasparini F., Kuhn R., et al. Potential anxiolytic- and antidepressant-like effects of MPEP, a potent, selective and systemically active mGlu5 receptor antagonist. British Journal of Pharmacology 2001, 132:1423-1430.
5. Belozertseva I.V., Kos T., Popik P., Danysz W., Bespalov A.Y. Antidepressant-like effects of mGluR1 and mGluR5 antagonists in the rat forced swim and the mouse tail suspension tests. European Neuropsychopharmacology 2007, 17:172-179.
6. Li X., Need A.B., Baez M., Witkin J.M. Metabotropic glutamate 5 receptor antagonism is associated with antidepressant-like effects in mice. Journal of Pharmacology and Experimental Therapeutics 2006, 319:254-259.
7. Spooren W.P., Vassout A., Neijt H.C., Kuhn R., Gasparini F., Roux S., et al. Anxiolytic-like effects of the prototypical metabotropic glutamate receptor 5 antagonist 2-methyl-6-(phenylethynyl)pyridine in rodents. Journal of Pharmacology and Experimental Therapeutics 2000, 295:1267-1275.
8. Inta D., Filipovic D., Lima-Ojeda J.M., Dormann C., Pfeiffer N., Gasparini F., et al. The mGlu5 receptor antagonist MPEP activates specific stress-related brain regions and lacks neurotoxic effects of the NMDA receptor antagonist MK-801: significance for the use as anxiolytic/antidepressant drug. Neuropharmacology 2012, 62:2034-2039.
9. Lu Y.M., Jia Z., Janus C., Henderson J.T., Gerlai R., Wojtowicz J.M., et al. Mice lacking metabotropic glutamate receptor 5 show impaired learning and reduced CA1 long-term potentiation (LTP) but normal CA3 LTP. Journal of Neuroscience 1997, 17:5196-5205.
10. Jia Z., Lu Y., Henderson J., Taverna F., Romano C., Abramow-Newerly W., et al. Selective abolition of the NMDA component of long-term potentiation in mice lacking mGluR5. Learning and Memory 1998, 5:331-343.
11. Gray L., van den Buuse M., Scarr E., Dean B., Hannan A.J. Clozapine reverses schizophrenia-related behaviours in the metabotropic glutamate receptor 5 knockout mouse: association with N-methyl-d-aspartic acid receptor up-regulation. International Journal of Neuropsychopharmacology 2009, 12:45-60.
12. Hannan A.J., Blakemore C., Katsnelson A., Vitalis T., Huber K.M., Bear M., et al. PLC-beta1, activated via mGluRs, mediates activity-dependent differentiation in cerebral cortex. Nature Neuroscience 2001, 4:282-288.
13. Wijetunge L.S., Till S.M., Gillingwater T.H., Ingham C.A., Kind P.C. mGluR5 regulates glutamate-dependent development of the mouse somatosensory cortex. Journal of Neuroscience 2008, 28:13028-13037.
14. Chourbaji S., Urani A., Inta I., Sanchis-Segura C., Brandwein C., Zink M., et al. IL-6 knockout mice exhibit resistance to stress-induced development of depression-like behaviors. Neurobiology of Disease 2006, 23:587-594.
15. Chourbaji S., Brandwein C., Vogt M.A., Dormann C., Hellweg R., Gass P. Nature vs. nurture: can enrichment rescue the behavioural phenotype of BDNF heterozygous mice?. Behavioural Brain Research 2008, 192:254-258.
16. Fuss J., Ben Abdallah N.M., Vogt M.A., Touma C., Pacifici P.G., Palme R., et al. Voluntary exercise induces anxiety-like behavior in adult C57BL/6J mice correlating with hippocampal neurogenesis. Hippocampus 2010, 20:364-376.
17. Fuss J., Ben Abdallah N.M., Hensley F.W., Weber K.J., Hellweg R., Gass P. Deletion of running-induced hippocampal neurogenesis by irradiation prevents development of an anxious phenotype in mice. PLoS ONE 2010, 5:e12769.
18. Strekalova T., Spanagel R., Bartsch D., Henn F.A., Gass P. Stress-induced anhedonia in mice is associated with deficits in forced swimming and exploration. Neuropsychopharmacology 2004, 29:2007-2017.
19. Ridder S., Chourbaji S., Hellweg R., Urani A., Zacher C., Schmid W., et al. Mice with genetically altered glucocorticoid receptor expression show altered sensitivity for stress-induced depressive reactions. Journal of Neuroscience 2005, 25:6243-6250.
20. Di Giorgi Gerevini V.D., Caruso A., Cappuccio I., Ricci Vitiani L., Romeo S., Della Rocca C., et al. The mGlu5 metabotropic glutamate receptor is expressed in zones of active neurogenesis of the embryonic and postnatal brain. Brain Research. Developmental Brain Research 2004, 150:17-22.
21. Zhao L., Jiao Q., Yang P., Chen X., Zhang J., Zhao B., et al. Metabotropic glutamate receptor 5 promotes proliferation of human neural stem/progenitor cells with activation of mitogen-activated protein kinases signaling pathway in vitro. Neuroscience 2011, 192:185-194.
22. Matta J.A., Ashby M.C., Sanz-Clemente A., Roche K.W., Isaac J.T. mGluR5 and NMDA receptors drive the experience- and activity-dependent NMDA receptor NR2B to NR2A subunit switch. Neuron 2011, 70:339-351.
23. Dolen G., Bear M.F. Role for metabotropic glutamate receptor 5 (mGluR5) in the pathogenesis of fragile×syndrome. Journal of Physiology 2008, 586:1503-1508.
24. Menard C., Quirion R. Successful cognitive aging in rats: a role for mGluR5 glutamate receptors, homer 1 proteins and downstream signaling pathways. PLoS ONE 2012, 7:e28666.